- Home
- ZYME vs CRSR Comparison
ZYME vs CRSR Comparison
Compare ZYME & CRSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYME
- CRSR
- Stock Information
- Founded
- ZYME 2003
- CRSR 1994
- Country
- ZYME United States
- CRSR United States
- Employees
- ZYME N/A
- CRSR N/A
- Industry
- ZYME Biotechnology: Pharmaceutical Preparations
- CRSR Computer Manufacturing
- Sector
- ZYME Health Care
- CRSR Technology
- Exchange
- ZYME Nasdaq
- CRSR Nasdaq
- Market Cap
- ZYME 983.6M
- CRSR 1.1B
- IPO Year
- ZYME 2017
- CRSR 2020
- Fundamental
- Price
- ZYME $11.91
- CRSR $8.86
- Analyst Decision
- ZYME Buy
- CRSR Buy
- Analyst Count
- ZYME 6
- CRSR 6
- Target Price
- ZYME $19.50
- CRSR $10.17
- AVG Volume (30 Days)
- ZYME 728.6K
- CRSR 889.6K
- Earning Date
- ZYME 03-05-2025
- CRSR 05-06-2025
- Dividend Yield
- ZYME N/A
- CRSR N/A
- EPS Growth
- ZYME N/A
- CRSR N/A
- EPS
- ZYME N/A
- CRSR N/A
- Revenue
- ZYME $76,304,000.00
- CRSR $1,316,379,000.00
- Revenue This Year
- ZYME $19.85
- CRSR $16.15
- Revenue Next Year
- ZYME $100.06
- CRSR $10.40
- P/E Ratio
- ZYME N/A
- CRSR N/A
- Revenue Growth
- ZYME 0.38
- CRSR N/A
- 52 Week Low
- ZYME $7.97
- CRSR $5.60
- 52 Week High
- ZYME $17.70
- CRSR $13.02
- Technical
- Relative Strength Index (RSI)
- ZYME 40.19
- CRSR 32.85
- Support Level
- ZYME $12.15
- CRSR $9.57
- Resistance Level
- ZYME $13.28
- CRSR $10.41
- Average True Range (ATR)
- ZYME 0.60
- CRSR 0.49
- MACD
- ZYME 0.03
- CRSR -0.20
- Stochastic Oscillator
- ZYME 22.22
- CRSR 9.16
About ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated product candidates. Its clinical candidate, zanidatamab, is a novel Azymetric HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About CRSR Corsair Gaming Inc.
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.